On August 11, 2023, Elevar Therapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
111,200 KRW | +1.65% | +4.61% | +119.33% |
1st Jan change | Capi. | |
---|---|---|
+119.33% | 10.38B | |
-3.37% | 186B | |
-2.32% | 107B | |
-3.91% | 67.44B | |
+3.09% | 50.03B | |
+16.17% | 47.81B | |
+4.79% | 41.03B | |
+1.57% | 26.85B | |
+2.90% | 25.82B | |
-0.49% | 25.01B |
- Stock Market
- Equities
- A028300 Stock
- News HLB Co., Ltd.
- Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.